John Pottage Jr, MD is a Non-Executive Director and Chair of the Development Committee for Spero Therapeutics, a biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant bacterial infections. His interests and expertise include infectious diseases, HIV medicine, research and development, good clinical practice, safety and pharmacovigilance, and regulatory affairs.